JBIO vs XOM · $868.2M cap vs P/E 24, rev $201.16B
Jade Biosciences, Inc. (JBIO) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Jade Biosciences, Inc. (JBIO) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE.
JBIO does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
JBIO currently screens at market cap $868.2M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the JBIO and XOM stock pages for the full models.
Not investment advice.